Ocata Therapeutics Announces New Pre-Clinical Data To Be Reported At The International Congress On Systemic Lupus Erythematosus

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Ocata Therapeutics, Inc. (“Ocata” or “the Company”; NASDAQ:OCAT), a leader in the field of Regenerative OphthalmologyTM, announced today that data will be presented at the 11th International Congress on Systemic Lupus Erythematosus, taking place in Vienna, Austria from September 2-6.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC